NCT07081451

Brief Summary

Depressive disorder is a common mental disorder. Depression, whose classic symptoms include depressed mood, anxiety, anhedonia and cognitive impairments that profoundly affect quality of life, is one of the leading causes of disability worldwide and the main cause of death by suicide. 3.8% of the world's population suffers from depression, including 5% of adults (4% of men and 6% of women) and 5.7% of those over 60 years of age. Approximately 280 million people worldwide are known to suffer from depression. Depression is often referred to as a stress-related disorder and stress caused by adverse life events, including early in life, is known to contribute to the onset, development and progression of this disorder. Studies have shown that high levels of exposure to negative stressors contribute significantly to cases of depression and that it is important to recognize stress exposures in a timely manner in these individuals. Research has also revealed that self-esteem plays an important role in depression. Self-esteem is defined as "a particular attitude and perception of one's self" that influences one's interactions and feelings towards oneself and others. Low self-esteem has been empirically shown to be a risk factor for the development of depression and suicidal ideation. Low self-esteem is a symptom of depressive disorders and is considered by some to be a precursor to relapse, while high self-esteem seems to buffer against depression. Although effective treatments for depression are available, not all patients receive treatment and of those who do, a significant proportion do not recover. New low-cost and easily accessible ways of dealing with the health burden of depression are increasingly recognized as important. There are a wide range of psychological interventions to treat depression, and one that has been shown to be effective in treating depression is psychoeducation. Psychoeducation is offered to help people with mental disorders understand and manage their illness. It is done by strengthening patients' resources and skills so that they can better cope with their condition, prevent relapse and contribute to their own health and well-being. Studies have shown that psychoeducation programs have positive effects on depression. Another method, Directed Imagery Technique (DIT), is an effective, economical and therapeutic technique that can be easily used in nursing practices. YIT is a set of stories that individuals create by visualizing the symbols given by the practitioner after relaxation exercises. Within the scope of this technique, which is a window to the inner world of the person, the creation of one's own unique story through symbols is encouraged. This randomized controlled experimental study will be conducted to evaluate the effect of guided imagery supported psychoeducation on depression, self-esteem and stress levels of individuals diagnosed with depression. The population of the study will consist of individuals diagnosed with depression who applied to Kilis Alaeddin Yavaşça State Hospital Psychiatry Outpatient Clinic. The sample of the study will consist of 60 individuals (30 experimental and 30 control) who applied to Kilis Alaeddin Yavaşça State Hospital Psychiatry Outpatient Clinic and agreed to participate in the study. In both groups, a face-to-face interview technique will be used to administer the Introductory Information Form, Beck Depression Scale (BDS), Rosenberg Self-Esteem Scale (RBSS) and Perceived Stress Scale (PSS) and the responses of the individuals will be recorded. The experimental group will be administered individually face-to-face twice a week for a total of three weeks. In addition, the audio recording made in a professional studio environment will be used for individuals to listen at home. Individuals will be instructed to listen to the audio recording twice a week for three weeks starting from the second week when the researcher started to apply the imagery technique. After the interventions applied to the experimental group are over, the scales will be applied again to the individuals in the experimental and control groups.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 23, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

8 months

First QC Date

May 29, 2025

Last Update Submit

July 14, 2025

Conditions

Keywords

depression, stress, self-esteem, guided imagery

Outcome Measures

Primary Outcomes (4)

  • Depression level

    The level of depression will be measured with the Beck Depression Scale. The level of depression severity is interpreted as "0-9=minimal, 10-16=mild, 17-29=moderate, 30-63=severe" according to the total score.

    Day 1

  • Self-esteem

    Self-esteem level will be measured with the Rosenberg Self-Esteem Scale. Those who score 0-1 on the scale are considered to have high self-esteem, those who score 2-4 are considered to have medium self-esteem, and those who score 5-6 are considered to have low self-esteem.

    Day 1

  • Stress

    The stress level will be measured with the Perceived Stress Scale. The lowest score that can be obtained from the scale is 0, the highest score is 56. High scores obtained from the scale indicate that the individual's perception of stress is high.

    Day 1

  • Stress

    The stress level will be measured with the Perceived Stress Scale. The lowest score that can be obtained from the scale is 0, the highest score is 56. High scores obtained from the scale indicate that the individual's perception of stress is high.

    up to four weeks

Secondary Outcomes (2)

  • Depression level

    up to four weeks

  • Self-esteem

    up to four weeks

Study Arms (2)

Experimental group consisting of individuals diagnosed with depression

EXPERIMENTAL

Included 30 patients diagnosed with depression

Other: Guided ımagery supported psychoeducation

Control group

NO INTERVENTION

Included 30 patients diagnosed with depression

Interventions

Guided Imagery Technique is an effective, economical and therapeutic technique that can be easily used in nursing practices. Guided Imagery Technique is a set of stories that individuals create by visualising the symbols given by the practitioner after relaxation exercises. Within the scope of this technique, which is a window to the inner world of the person, the creation of his/her own unique story through symbols is encouraged

Also known as: Imagery supported psychoeducation, Guided imagination supported psychoeducation
Experimental group consisting of individuals diagnosed with depression

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • To be literate
  • Being followed up with a diagnosis of depression according to DSM V criteria for at least one month and receiving medication
  • Not being a suicide attempt
  • Not having received ECT in the last 1 year
  • No cognitive and communication disabilities that would prevent continuing the interview and completing the questionnaires
  • Being able to use a smartphone
  • To agree to participate in the study after being informed

You may not qualify if:

  • \- Under 18 years of age
  • Illiteracy
  • Not being followed up with a diagnosis of depression according to DSM V criteria for at least one month and not receiving medication
  • Being a suicide attempt
  • Having received ECT within the last 1 year
  • Comorbid mental illness
  • Having cognitive and communication disabilities that would prevent continuing the interview and completing the questionnaires
  • Refusing to participate in the study after being informed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kilis 7 Aralik University

Kilis, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
LECTURER

Study Record Dates

First Submitted

May 29, 2025

First Posted

July 23, 2025

Study Start

December 23, 2024

Primary Completion

August 15, 2025

Study Completion

September 15, 2025

Last Updated

July 23, 2025

Record last verified: 2025-07

Locations